受强制性开放获取政策约束的文章 - Johannes Waldschmidt, MD了解详情
可在其他位置公开访问的文章：10 篇
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma
J Frede, P Anand, N Sotudeh, RA Pinto, MS Nair, H Stuart, AJ Yee, ...
Nature cell biology 23 (11), 1199-1211, 2021
强制性开放获取政策： US National Institutes of Health, German Research Foundation, V Foundation, USA
Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease
JM Waldschmidt, P Anand, B Knoechel, JG Lohr
Seminars in hematology 55 (1), 33-37, 2018
强制性开放获取政策： US National Institutes of Health
Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in …
JM Waldschmidt, A Keller, G Ihorst, O Grishina, S Müller, D Wider, AV Frey, ...
Haematologica 103 (10), e473, 2018
强制性开放获取政策： German Research Foundation
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma
JM Waldschmidt, JA Kloeber, P Anand, J Frede, A Kokkalis, V Dimitrova, ...
Clinical Cancer Research 27 (23), 6432-6444, 2021
强制性开放获取政策： US National Institutes of Health, German Research Foundation, V Foundation, USA
Cell-free DNA for the detection of emerging treatment failure in relapsed/refractory multiple myeloma
JM Waldschmidt, AJ Yee, T Vijaykumar, RA Pinto, J Frede, P Anand, ...
Leukemia 36 (4), 1078-1087, 2022
强制性开放获取政策： US National Institutes of Health, German Research Foundation, V Foundation, USA
Tracking myeloma tumor DNA in peripheral blood
JM Waldschmidt, T Vijaykumar, B Knoechel, JG Lohr
Best Practice & Research Clinical Haematology 33 (1), 101146, 2020
强制性开放获取政策： US National Institutes of Health, German Research Foundation, V Foundation, USA
Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib
J Eismann, YJ Heng, JM Waldschmidt, IS Vlachos, KP Gray, UA Matulonis, ...
Journal of cancer research and clinical oncology 146, 503-514, 2020
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Regulatory programs of B-cell activation and germinal center reaction allow B-ALL escape from CD19 CAR T-cell therapy
NG Im, A Guillaumet-Adkins, M Wal, AJ Rogers, J Frede, CC Havig, ...
Cancer immunology research 10 (9), 1055-1068, 2022
强制性开放获取政策： US National Institutes of Health
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
K Maas-Bauer, AV Stell, KL Yan, E de Vega, JM Vinnakota, S Unger, ...
Nature communications 15 (1), 446, 2024
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health, German …
Current antibody-based therapies for the treatment of multiple myeloma
C Varga, JM Waldschmidt, S Gandolfi, PG Richardson
Clin Adv Hematol Oncol 18 (11), 736-748, 2020
强制性开放获取政策： German Research Foundation
出版信息和资助信息由计算机程序自动确定